Life Sciences

HOYNG ROKH MONEGIER has a long history of working with innovative pharmaceutical companies to protect and maximize their intellectual property rights and assets. Our top-tier litigators help many of the world's largest pharmaceutical companies achieve their goals by advising on and litigating issues relating to patent and SPC infringement and validity, regulatory data protection, theft of trade secrets, antitrust violations, trade marks and advertising.

We also act for innovative clients of all sizes, from global leaders to small start-ups, in the medical devices and diagnostics sector.

Our Life Sciences Regulatory practice covers all aspects of the development of medicinal products and medical devices. We advise on clinical trials (GCP), market authorisations, regulatory exclusivity, manufacturing (GMP), supply chain management, pharmaco- and materiovigilance, distribution, marketing and promotion, compliance, relationships with healthcare professionals, market access (in particular pricing and reimbursement strategies), patient support programmes, parallel trade, tenders, and privacy and data protection.

We advise and represent clients in their dealings with EU and national regulatory authorities and, if necessary, before the EU and national courts. For many years, we have represented the headquarters and local entities of a number of global pharmaceutical and biotech companies in EU and cross-border litigation and coordinated their legal representation across the EU.